Search
Adalimumab, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, secukinumab i ustekinumab: per al tractament de l'artritis psoriàsica activa en pacients adults quan la resposta als fàrmacs antireumàtics modificadors de la malaltia ha estat inadequada
(2018-06-12)
Psoriatic arthritis (APs) is a chronic inflammatory disease of the musculoskeletal system associated with psoriasis. It is a heterogeneous disease with a wide variety of clinical manifestations: peripheral arthritis, axial ...
Factors de risc dels pacients amb un esdeveniment cardiovascular: anys 2012-2017 (21/2018)
(2018-10)
The diseases of the cardiovascular system are the second cause of death in Catalonia, with
27% of the total deaths in Catalonia (29% in women and 25% in men). This set of diseases has a great impact on the quality of ...
Sarilumab per al tractament de l'artritis reumatoide activa, de moderada a greu en pacients adults quan la resposta als fàrmacs antireumàtics modificadors de la malaltia (FAMM) inclòs el metotrexat (MTX) ha estat inadequada
(2018-06-25)
Rheumatoid arthritis (AR) is a chronic systemic autoimmune disease that is a serious cause of unknown etiology that mainly affects synovial joints although it can also be used with systemic manifestations. Rheumatoid ...
Darvadstrocel per al tractament de fístules perianals complexes en pacients amb malaltia de Crohn
(2018-07-19)
Crohn's disease (MC) is a chronic, progressive, inflammatory bowel disease (IBD).
destructive and relapsing, characterized by transmural inflammation and the formation of fistulas. Fistulas may be perianal or appear between ...
Pacients amb sèpsia: descripció i utilització de recursos; Catalunya 2005 -2016 (11/2018)
(2018-03)
Since the year 2015, the Sepsis Code has existed throughout Catalonia. This comprehensive care model seeks to reduce the response time of the healthcare system, favor the detection and coordination of all resources, so ...
Combinacions a dosis fixes d’un anticolinèrgic d’acció llarga i un agonista beta-2 d’acció llarga per al tractament de manteniment de la malaltia pulmonar obstructiva crònica
(2018-04-18)
Chronic obstructive pulmonary disease (MPOC) is a respiratory disorder characterized by chronic persistence and chronic limitation of flux, mainly causing cancer. It suffers a problem of public health of great magnitude ...
Paclitaxel unit a l'albúmina: tractament de primera línia del càncer de pàncrees metastàtic
(2018-04-04)
Pancreatic cancer is one of the most aggressive and with less healing percentage. In Europe, pancreatic cancer is the seventh most common cancer, and represents 2.9% of cancer in men and 3.2% in women. It is also the fifth ...
Malaltia d'Alzehimer: característiques i utilització de recursos sanitaris; any 2016 (19/2018)
(2018-09)
Alzheimer's (MA) is the main disease cause of dementia in older people of 65 years. It is a neurodegenerative disorder progressive brain that causes problems of memory, reasoning and behavior. In MA causes a decrease of ...
Osimertinib: indicació avaluada; tractament de pacients adults amb càncer de pulmó no microcític avançat o metastàsic amb mutació EGFR T790M positiva
(2018-07-05)
Lung cancer is the leading cause of cancer-related mortality around the world. The most frequent histological subtype (85% of patients) is non-microcytic lung cancer (CPNM). CPNM is classified according to histology in ...
Cladribina per al tractament de l'esclerosi múltiple en pacients adults
(2018-11-28)
Multiple sclerosis (MS) is a chronic central nervous system (CNS) disease that is
It is characterized by inflammation, demyelination, glial scarring and neuroaxonal degeneration. Its etiology is not entirely known, although ...